Deconvolution analysis identified altered hepatic cell landscape in primary sclerosing cholangitis and primary biliary cholangitis

被引:0
|
作者
Pham, Hoang Nam [1 ]
Pham, Linh [2 ]
Sato, Keisaku [3 ]
机构
[1] Vietnam Acad Sci & Technol, Univ Sci & Technol Hanoi, Dept Life Sci, Hanoi, Vietnam
[2] Texas A&M Univ, Dept Sci & Math, Cent Texas, Killeen, TX USA
[3] Indiana Univ Sch Med, Dept Med, Div Gastroenterol & Hepatol, Indianapolis, IN 46202 USA
关键词
deconvolution analysis; CIBERSORTx; primary sclerosing cholangitis; primary biliary cholangitis; hepatic cell landscape; PLASMA-CELLS; CHOLANGIOCYTES; ACTIVATION; EXPRESSION; DAMAGE;
D O I
10.3389/fmed.2024.1327973
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction Primary sclerosing cholangitis (PSC) and primary biliary cholangitis (PBC) are characterized by ductular reaction, hepatic inflammation, and liver fibrosis. Hepatic cells are heterogeneous, and functional roles of different hepatic cell phenotypes are still not defined in the pathophysiology of cholangiopathies. Cell deconvolution analysis estimates cell fractions of different cell phenotypes in bulk transcriptome data, and CIBERSORTx is a powerful deconvolution method to estimate cell composition in microarray data. CIBERSORTx performs estimation based on the reference file, which is referred to as signature matrix, and allows users to create custom signature matrix to identify specific phenotypes. In the current study, we created two custom signature matrices using two single cell RNA sequencing data of hepatic cells and performed deconvolution for bulk microarray data of liver tissues including PSC and PBC patients.Methods Custom signature matrix files were created using single-cell RNA sequencing data downloaded from GSE185477 and GSE115469. Custom signature matrices were validated for their deconvolution performance using validation data sets. Cell composition of each hepatic cell phenotype in the liver, which was identified in custom signature matrices, was calculated by CIBERSORTx and bulk RNA sequencing data of GSE159676. Deconvolution results were validated by analyzing marker expression for the cell phenotype in GSE159676 data.Results CIBERSORTx and custom signature matrices showed comprehensive performance in estimation of population of various hepatic cell phenotypes. We identified increased population of large cholangiocytes in PSC and PBC livers, which is in agreement with previous studies referred to as ductular reaction, supporting the effectiveness and reliability of deconvolution analysis in this study. Interestingly, we identified decreased population of small cholangiocytes, periportal hepatocytes, and interzonal hepatocytes in PSC and PBC liver tissues compared to healthy livers.Discussion Although further studies are required to elucidate the roles of these hepatic cell phenotypes in cholestatic liver injury, our approach provides important implications that cell functions may differ depending on phenotypes, even in the same cell type during liver injury. Deconvolution analysis using CIBERSORTx could provide a novel approach for studies of specific hepatic cell phenotypes in liver diseases.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] Epigenetics in the Primary Biliary Cholangitis and Primary Sclerosing Cholangitis
    Cheung, Angela C.
    LaRusso, Nicholas F.
    Gores, Gregory J.
    Lazaridis, Konstantinos N.
    SEMINARS IN LIVER DISEASE, 2017, 37 (02) : 159 - 174
  • [2] Novel Insights of Primary Sclerosing Cholangitis and Primary Biliary Cholangitis
    Ahn, Dong-Won
    KOREAN JOURNAL OF GASTROENTEROLOGY, 2020, 75 (05) : 246 - 256
  • [3] Autoimmune biliary diseases: primary biliary cholangitis and primary sclerosing cholangitis
    Sarcognato, Samantha
    Sacchi, Diana
    Grillo, Federica
    Cazzagon, Nora
    Fabris, Luca
    Cadamuro, Massimiliano
    Cataldo, Ivana
    Covelli, Claudia
    Mangia, Alessandra
    Guido, Maria
    PATHOLOGICA, 2021, 113 (03) : 170 - 184
  • [4] Primary Biliary Cholangitis and Primary Sclerosing Cholangitis: Current Knowledge of Pathogenesis and Therapeutics
    Park, Ji-Won
    Kim, Jung-Hee
    Kim, Sung-Eun
    Jung, Jang Han
    Jang, Myoung-Kuk
    Park, Sang-Hoon
    Lee, Myung-Seok
    Kim, Hyoung-Su
    Suk, Ki Tae
    Kim, Dong Joon
    BIOMEDICINES, 2022, 10 (06)
  • [5] A patient with primary biliary cholangitis, autoimmune hepatitis, and primary sclerosing cholangitis variant syndrome
    Beretta-Piccoli, Benedetta Terziroli
    Mazzucchelli, Luca
    Taiana, Chiara
    Mossi, Giuseppe
    Usai, Corrado
    Vergani, Diego
    Mieli-Vergani, Giorgina
    JOURNAL OF TRANSLATIONAL AUTOIMMUNITY, 2020, 3
  • [6] Cholestatic Liver Injury: Care of Patients With Primary Biliary Cholangitis or Primary Sclerosing Cholangitis
    Larson, Laurie
    James, Michelle
    Gossard, Andrea
    AACN ADVANCED CRITICAL CARE, 2016, 27 (04) : 441 - 452
  • [7] Autoimmune Biliary Diseases A Review of Primary Biliary Cholangitis, Primary Sclerosing Cholangitis, Immunoglobulin G4-Related Sclerosing Cholangitis, and Autoimmune Hepatitis
    Evans, Suzanne
    Hofmann, Alana
    SURGICAL CLINICS OF NORTH AMERICA, 2024, 104 (06) : 1249 - 1261
  • [8] Phenotyping and auto-antibody production by liver-infiltrating B cells in primary sclerosing cholangitis and primary biliary cholangitis
    Chung, Brian K.
    Guevel, Bardia T.
    Reynolds, Gary M.
    Udatha, D. B. R. K. Gupta
    Henriksen, Eva Kristine Klemsdal
    Stamataki, Zania
    Hirschfield, Gideon M.
    Karlsen, Tom Hemming
    Liaskou, Evaggelia
    JOURNAL OF AUTOIMMUNITY, 2017, 77 : 45 - 54
  • [9] Cholestatic Pruritus Treatments in Primary Biliary Cholangitis and Primary Sclerosing Cholangitis: A Systematic Literature Review
    Smith, Helen T.
    de Souza, Andrea Ribeiro
    Thompson, April H.
    McLaughlin, Megan M.
    Dever, John J.
    Myers, Julie A.
    Chen, Jing Voon
    DIGESTIVE DISEASES AND SCIENCES, 2023, 68 (06) : 2710 - 2730
  • [10] Geo-epidemiology and environmental co-variate mapping of primary biliary cholangitis and primary sclerosing cholangitis
    Dyson, Jessica Katharine
    Blain, Alasdair
    Shirley, Mark David Foster
    Hudson, Mark
    Rushton, Steven
    Jones, David Emrys Jeffreys
    JHEP REPORTS, 2021, 3 (01)